Shares of Corbus Pharmaceuticals Holdings Inc. CRBP were unchanged Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.82% to 11,801.60 and Dow Jones Industrial Average DJIA falling 1.16% to 29,438.42. Corbus Pharmaceuticals Holdings Inc. closed $8.58 short of its 52-week high ($9.78), which the company reached on August 31st.
The stock outperformed some of its competitors Wednesday, as Fate Therapeutics Inc. FATE fell 5.15% to $49.72, Vanda Pharmaceuticals Inc. VNDA fell 3.25% to $12.82, and Viking Therapeutics Inc. VKTX fell 2.49% to $6.26. Trading volume (3.7 M) remained 1.6 million below its 50-day average volume of 5.3 M.